HIV molecular immunology database
Found 1 matching record:
| HXB2 Location | Gag(92-101) | Gag Epitope Map
View variants at this location |
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epitope |
IEVKDTKEAL
|
Epitope Alignment | |||||||||||||||||||||||||
| Variants |
|
||||||||||||||||||||||||||
| Epitope Name | IL10-B40 | ||||||||||||||||||||||||||
| Species (MHC/HLA) | human | ||||||||||||||||||||||||||
Showing all: 8 variant(s).
| Variant ID. | 3888 |
|---|---|
| Epitope Seq. | IEVKDTKEAL |
| Variant Seq. | IEVKDTrEAL |
| Mutations | K/R |
| Epitope Location | K7R |
| HXB2 Location | K98R |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 2/10 HIV-1 sequences in Subject 12 carried an K98R variation within epitope IL10 at 3 months post-infection, IEVKDTrEAL, with no flanking mutations. |
| Variant ID. | 3889 |
|---|---|
| Epitope Seq. | IEVKDTKEAL |
| Variant Seq. | IgVKDTKEAL |
| Mutations | E/G |
| Epitope Location | E2G |
| HXB2 Location | E93G |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 1/12 HIV-1 sequences in Subject 12 carried an E93G variation within epitope IL10 at 1 year post-infection, IgVKDTKEAL, with no flanking mutations. |
| Variant ID. | 3890 |
|---|---|
| Epitope Seq. | IEVKDTKEAL |
| Variant Seq. | IEiKDTKEAL |
| Mutations | V/I |
| Epitope Location | V3I |
| HXB2 Location | V94I |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 1/12 HIV-1 sequences in Subject 12 carried an V94I variation within epitope IL10 at 1 year post-infection, IEiKDTKEAL, with no flanking mutations. |
| Variant ID. | 3891 |
|---|---|
| Epitope Seq. | IEVKDTKEAL |
| Variant Seq. | IEVKDTKEAv |
| Mutations | L/V |
| Epitope Location | L10V |
| HXB2 Location | L101V |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 1/12 HIV-1 sequences in Subject 12 carried an L101V variation within epitope IL10 at 1 year post-infection, IEVKDTKEAv, with no flanking mutations. |
| Variant ID. | 3892 |
|---|---|
| Epitope Seq. | {HQK}IEVKDTKEAL{DKLEE} |
| Variant Seq. | {HQr}IEVKDTKEAv{DKLEE} |
| Mutations | L/V K/R |
| Epitope Location | L+1V K-1R |
| HXB2 Location | L102V K91R |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 3/12 HIV-1 sequences in Subject 12 carried K91R, L101V variations within epitope IL10 at 1 year post-infection, IEVKDTKEAv, with the upstream flanking mutation at -1 position. |
| Variant ID. | 3893 |
|---|---|
| Epitope Seq. | {HQK}IEVKDTKEAL{DKLEE} |
| Variant Seq. | {HQr}IgVKDTKEAL{DKLEE} |
| Mutations | K/R E/G |
| Epitope Location | K-1R E2G |
| HXB2 Location | K91R E93G |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 2/12 HIV-1 sequences in Subject 12 carried K91R, E93G variations within epitope IL10 at 1 year post-infection, IgVKDTKEAL, with the upstream flanking mutation at -1 position. |
| Variant ID. | 3894 |
|---|---|
| Epitope Seq. | {HQK}IEVKDTKEAL{DKLEE} |
| Variant Seq. | {HQr}IaVKDTKEAL{DKLEE} |
| Mutations | K/R E/A |
| Epitope Location | K-1R E2A |
| HXB2 Location | K91R E93A |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 2/12 HIV-1 sequences in Subject 12 carried K91R, E93A variations within epitope IL10 at 1 year post-infection, IaVKDTKEAL, with the upstream flanking mutation at -1 position. |
| Variant ID. | 3895 |
|---|---|
| Epitope Seq. | {HQK}IEVKDTKEAL{DKLEE} |
| Variant Seq. | {HQr}IEVKDTKEAL{DKLEE} |
| Mutations | K/R |
| Epitope Location | K-1R |
| HXB2 Location | K91R |
| Mutation Type | OV: observed variant |
| Epitope Subtype | CRF01_AE |
| Variant Subtype | CRF01_AE |
| Method | Other, Sequence |
| Note | 1/10 HIV-1 sequences in Subject 12 carried a K91R variation flanking epitope IL10 at 3 months post-infection, with the upstream flanking mutation at -1 position. |
Jiang2016 Xifeng Jiang, Qiyan Jia, Lu Lu, Fei Yu, Jishen Zheng, Weiguo Shi, Lifeng Cai, Shibo Jiang, and Keliang Liu. A Novel Bispecific Peptide HIV-1 Fusion Inhibitor Targeting the N-Terminal Heptad Repeat and Fusion Peptide Domains in gp41. Amino Acids, 48(12):2867-2873, Dec 2016. PubMed ID: 27631437. Show all entries for this paper.